CD8A and neoplasm: These data suggest platinum-resistant tumors have an IDO1- and TDO2-dependent metabolic impact (higher KYN/lower TRP) on the tumor microenvironment by promoting immunosuppression (higher Treg and MDSC frequencies, lower % of NKG2D NK+ and CD8+ cells).